日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma

帕博利珠单抗与其他免疫检查点抑制剂在食管鳞状细胞癌新辅助化疗免疫治疗中的疗效比较

Chen, Mingduan; Xie, Shuhan; Hong, Zhinuan; Kang, Mingqiang

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study

新辅助化疗免疫治疗食管鳞状细胞癌患者主要病理反应的预后价值:一项多中心队列研究

Xie, Shuhan; Huang, Shijie; Tang, Zilu; Zhang, Hai; Xu, Jinxin; Ke, Sunkui; Xie, Jinbiao; Xu, Rongyu; Chen, Ying; Hong, Zhinuan; Kang, Mingqiang

High comprehensive complication index after minimally invasive esophagectomy associated with poor short-term and long-term outcome: a propensity score matching analysis

微创食管切除术后高综合并发症指数与短期和长期预后不良相关:倾向评分匹配分析

Wang, Xiaoqing; Yu, Jingchuan; Xie, Shuhan; Lin, Ye; Zhang, Peipei; Gao, Lei; Hong, Zhinuan; Kang, Mingqiang

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis

新辅助免疫化疗后至食管切除术的时间间隔对局部晚期食管鳞状细胞癌的影响:一项多中心回顾性队列分析

Xu, Hui; Hong, Zhinuan; Lin, Ye; Ke, Sunkui; Chen, Zhen; Xie, Shuhan; Chen, Dinghang; Peng, Kaiming; Zhang, Peipei; Chen, Mingduan; Han, Ziyang; Lin, Jihong; Chen, Shuchen; Xu, Jinxin; Xie, Jinbiao; Kang, Mingqiang

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis

二型糖尿病、二甲双胍、胰岛素、格列齐特与食管癌之间的因果关系——来自双样本孟德尔随机化研究和荟萃分析的启示

Lin, Ye; Lin, Junhuang; Xu, Hui; Hong, Zhinuan; Kang, Mingqiang

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma

阐明 CYFIP2 在食管鳞状细胞癌产生顺铂耐药性中的作用

Peipei Zhang #, Weiguang Zhang #, Zhinuan Hong #, Junfei Jiang, Ningzi Wu, Jihong Lin, Mingqiang Kang

Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China

炎症营养评分在接受新辅助化疗免疫治疗的局部晚期食管鳞状细胞癌患者中的预后价值:一项中国多中心研究

Xu, Jinxin; Hong, Zhinuan; Cai, Yingjie; Chen, Zhen; Lin, Jingping; Yuan, Xi; Chen, Shuchen; Xie, Jinbiao; Kang, Mingqiang; Ke, Sunkui

Prognostic nomogram for overall survival of elderly esophageal cancer patients receiving neoadjuvant therapy: a population-based analysis

接受新辅助治疗的老年食管癌患者总生存期预后列线图:一项基于人群的分析

Peng, Kaiming; Xu, Hui; Xie, Shuhan; Weng, Kai; Lagarde, Sjoerd M; Hong, Zhinuan; Lin, Wenwei; Kang, Mingqiang

Additional neoadjuvant immunotherapy does not increase the risk of anastomotic leakage after esophagectomy for esophageal squamous cell carcinoma: a multicenter retrospective cohort study

一项多中心回顾性队列研究表明,新辅助免疫疗法不会增加食管鳞状细胞癌食管切除术后吻合口漏的风险。

Hong, Zhinuan; Xu, Jinxin; Chen, Zhen; Xu, Hui; Huang, Zhixin; Weng, Kai; Cai, Junlan; Ke, Sunkui; Chen, Shuchen; Xie, Jinbiao; Duan, Hongbing; Kang, Mingqiang

Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study

估计IA期肺腺癌的治愈率:一项基于人群的研究

Huang, Zhixin; Chen, Dinghang; Hong, Zhinuan; Kang, Mingqiang